STRO
Sutro Biopharma
15.40$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +572.0% | -88.6% | +97.6% | -66.9% | +73.8% | +17.5% | +266.4% | -84.8% | +20.2% | +24.7% | -32.3% | – | |
| – | +298.8% | +1.7% | +1.6% | +0.5% | -196.6% | – | – | +0.0% | -14.5% | -21.3% | – | – | |
| – | +572.0% | -90.1% | +112.6% | -64.4% | +73.8% | +17.5% | +266.4% | -84.8% | +20.2% | +13.7% | -25.7% | – | |
| – | +17.7% | +5.8% | +9.0% | +0.1% | +14.4% | -27.4% | -25.7% | +4.0% | -8.1% | -0.2% | -13.3% | – | |
| – | +10.1% | -24.3% | -2.8% | +15.8% | -37.0% | +47.0% | -22.1% | -15.5% | -0.9% | -12.4% | +3.3% | – | |
| – | +15.8% | -3.9% | +7.0% | +5.3% | +4.7% | +7.3% | -21.9% | -13.3% | -22.1% | -5.4% | -7.3% | – | |
| – | – | -231.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +7.6% | -3.8% | -12.5% | +9.9% | +22.5% | -9.4% | +7.9% | -0.7% | -8.3% | +4.2% | – | |
| – | – | -224.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +759.5% | -89.1% | -99.5% | – | – | – | – | – | – | – | – | – | |
| – | – | -287.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -185.9% | – | – | – | – | – | -4,248.0% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.